According to the most recent analysis by Reports and Data, the size of the worldwide Chimeric Antigen Receptor (CAR) T-Cell Therapy Market is anticipated to reach USD 21 billion in 2028 and show a CAGR of 20.4% over the projected period. The incidence of malignancies and the growing elderly population around the world are two important variables that are propelling market revenue...